BRCA1 and breast cancer: Furthermore, Swedish national guidelines recommend that RM specimens undergo histopathologic examination for patients aged ≥40 years, except in cases of a family history of breast cancer or the presence of genetic mutations (e.g., BRCA1/2) [56].